Mednet Logo
SpecialtiesOphthalmology
Ophthalmology

Ophthalmology

Expert insights on ocular conditions, surgical techniques, retinal disease, and vision-related management.

Recent Discussions

How do you determine when to discontinue anti-complement therapy in patients with geographic atrophy who already have center-involving disease given the minimal likelihood of central vision improvement but the potential for more rapid scotoma expansion if treatment is withdrawn?

1
2 Answers

Mednet Member
Mednet Member
Ophthalmology · Advanced Eye Centers Inc

Since these drugs have a significant risk and a marginal benefit, not to mention the significant treatment burden and their outrageous cost, it begs the question of how often they should be used altogether.

How often do you recommend ophthalmologic screening exams for patients with sarcoidosis?

4 Answers

Mednet Member
Mednet Member
Rheumatology · Legacy Devers Eye Institute

The American Academy of Ophthalmology has guidelines for routine eye exams for an asymptomatic, healthy individual (not someone with sarcoidosis). These guidelines include a complete, dilated eye exam at age 40, interim exams at the discretion of the patient and one's ophthalmologist, and an exam ev...

How do you approach management of GLP-1 receptor agonist therapy in patients who develop NAION?

1
2 Answers

Mednet Member
Mednet Member
Ophthalmology · The George Washington University School of Medicine & Health Sciences

Short answer is I recommend stopping the GLP-1 agonist if one eye has already developed NAION, for the sake of protecting the fellow eye. The fact is, our knowledge is still growing in this matter. While some studies indicate links between GLP-1 agonists and NAION, there are so many discussions arou...

In what cases do you consider mannitol for cataract surgery?

4
3 Answers

Mednet Member
Mednet Member
Ophthalmology · Redman Gelinas Eye Care

I have found IV mannitol VERY helpful for dehydrating vitreous for short axial length, especially around 20.5 or less. Otherwise, in short eyes, there is less working space and a greater tendency for the iris to want to prolapse out, even in the absence of typical IFIS-type medications. I’ve typical...

How do you approach cases of zonular dehisence/weakness noticed intra-op?

1
1 Answers

Mednet Member
Mednet Member
Ophthalmology · University of Minnesota

For dehiscence of less than 90 degrees, placing CTR seems the safest and easiest way. Published studies suggest CTR use in zonular dialysis or weak zonules can improve postoperative visual or refractive outcomes in many cases. For 180 degrees of zonular loss, I try to preserve the anatomy if possibl...

In extensive basal cell carcinoma involving both upper and lower eyelids and the lacrimal gland, is radiotherapy poorly tolerated (especially to doses up to 50-60 Gy) and/or is orbital exenteration preferred?

1
1 Answers

Mednet Member
Mednet Member
Ophthalmology · The Ohio State University Wexner Medical Center

For advanced basal cell carcinoma with orbital invasion, I would treat with hedgehog inhibitors. If there is an inadequate clinical response, exenteration is usually recommended. Radiation is not particularly effective for BCC and can have significant ocular side effects.

What specific exam findings or test changes prompt escalation of care when evaluating pediatric patients with optic disc drusen for possible increased intracranial pressure?

2
1 Answers

Mednet Member
Mednet Member
Ophthalmology · The George Washington University School of Medicine & Health Sciences

Both pediatric and adult patients with optic disc drusen can develop increased intracranial pressure, including IIH, like normal individuals. This is important to remember, especially if the symptoms and risk factors suggest elevated intracranial hypertension. In the pediatric group, especially youn...

How do you incorporate OCT and OCT-A in conjunction with FA in your evaluation of retinal diseases?

3
1 Answers

Mednet Member
Mednet Member
Ophthalmology · University of Arkansas for Medical Science

There are no clinical or diagnostic factors that predict who will benefit from an intervention for vitreous floaters. Symptomatology from vitreous floaters is subjective. Patient-reported outcome measures after floaterectomy are also subjective. The improvement in symptoms following vitrectomy (I do...

How do you manage the severe adverse drug reaction of central serous retinopathy with MEK inhibitors?

1
2 Answers

Mednet Member
Mednet Member
Ophthalmology · Stanford University School of Medicine

Fortunately, the ICSC-like association of subretinal fluid with MEK inhibitor exposure is usually reversible after cessation of the drug. When working with this class of medications, it is important to coordinate care with the treating oncologist. If a patient presents with subretinal fluid and is o...

What is your algorithm for transitioning a patient with chronic noninfectious posterior uveitis from corticosteroids to immunosuppressive therapy?

1
1 Answers

Mednet Member
Mednet Member
Ophthalmology · Tennessee Retina Pc

There are some forms of noninfectious posterior/panuveitis where it is known from the time of uveitis diagnosis that steroid-sparing immunosuppression (IMT) will be needed. For example, in birdshot retinochoroiditis or serpiginous choroidopathy, IMT is often initiated in concert with oral corticoste...